Photoelectric Therapy System
System, Therapeutic, X-Ray. 510(k) K172080, from Xstrahl, Ltd. (Brownhills, GB). Product code JAD, class 2.
As of Nov 20, 2026, K172080 is an FDA 510(k) held by Xstrahl, Ltd., substantially equivalent on Sep 29, 2017 after 81 days, with 2 recalls tied to it in FDA's recall database.
- Review time: 81 days
- Recalls: 2
- Cited as a predicate by: 1 device
The Xstrahl Photoelectric Therapy System is a low energy X-Ray system intended for superficial radiotherapy and surface electronic brachytherapy treatment of primary malignant epithelial neoplasms of the skin and keloids.
- Sensus Healthcare Superficial Radiotherapy System SRT-100K123985 · Sensus Healthcare · May 14, 2013
- X80 / RADiant / PhotoElectric Therapy System (RADiant Aura)K230611 · Xstrahl, Ltd. · Jul 13, 2023
| Apr 27, 2022 | Z-1404-2022There is a potential compatibility issue with the systems and replacement treatment applicators. | Open |
| Apr 26, 2021 | Z-0174-2022If a saved treatment plan with 2 opposing beams is edited prior to approval, then Beam 2 is not updated with the changed parameters upon selecting save, resulting in error messages during the treatment and possible… | Terminated |
- GentleBeam (GB1000)K250692 · Voxel Ray Solutions, LLC · Dec 3, 2025
- INTRABEAM (700); And accessories (INTRABEAM SMART Stand, INTRABEAM SMART Spherical Applicator, INTRABEAM Spherical…K241174 · Carl Zeiss Meditec, AG · Jan 10, 2025
- X80 / RADiant / PhotoElectric Therapy System (RADiant Aura)K230611 · Xstrahl, Ltd. · Jul 13, 2023
- EsteyaK213942 · Nucletron B.V. · Jan 11, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 10, 2017
- Review panel
- Radiology
- Regulation
- 21 CFR 892.5900
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files